Validation of blood biomarkers for Alzheimer Disease in Thai Cohort
Plasma biomarkers showed promising diagnostic performances and potential clinical usefulness in diagnosing dementia. Plasma p-tau217 was best differentiates AD positive from AD negative groups, followed by plasma GFAP, pTau181, and Aβ42/40 ratio. Thank you Health Systems Research Institute (Thailand) grant support for this study.
Authors
- Chatchawan Rattanabannakit (ORCID: https://orcid.org/0000-0001-9769-9556)
- Tanyaluck Thientunyakit (ORCID: https://orcid.org/0000-0002-6139-7887)
- Atthapon Raksthaput
- Pathitta Dujada (ORCID: https://orcid.org/0000-0003-4905-6075)
- Lertchai Wachirutmangur
- Natthamon Wongkom
- Sunisa Chaichanettee
- Philip Scheltens
- Paphawadee Phoyoo
- Vorapun Senanarong
Institutions
- Siriraj Hospital (TH)
- Mahidol University (TH)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- Amsterdam University of Applied Sciences (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102473
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00